| NDC Number | Brand Name | Generic Name | Manufacturer | Dosage Form | DEA Sch. | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0143-9367 | Methotrexate | Methotrexate | Hikma Pharmaceuticals USA Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2005-09-06 | |
| 0143-9516 | Methotrexate | Methotrexate | Hikma Pharmaceuticals USA Inc. | SOLUTION | 2018-01-05 | |
| 0143-9517 | Methotrexate | Methotrexate | Hikma Pharmaceuticals USA Inc. | SOLUTION | 2018-01-05 | |
| 0143-9518 | Methotrexate | Methotrexate | Hikma Pharmaceuticals USA Inc. | SOLUTION | 2018-01-05 | |
| 0143-9519 | Methotrexate | Methotrexate | Hikma Pharmaceuticals USA Inc. | SOLUTION | 2017-10-10 | |
| 0143-9830 | Methotrexate | Methotrexate | Hikma Pharmaceuticals USA Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2005-09-06 | |
| 0904-7141 | Methotrexate | Methotrexate | Major Pharmaceuticals | TABLET | 2017-02-09 | |
| 16729-277 | Methotrexate | Methotrexate | Accord Healthcare, Inc. | INJECTION | 2014-03-07 | |
| 52652-2001 | Xatmep | Methotrexate | Azurity Pharmaceuticals, Inc. | SOLUTION | 2017-05-01 | |
| 54436-010 | Otrexup | methotrexate | Antares Pharma, Inc. | INJECTION, SOLUTION | 2013-10-11 | |
| 54436-012 | Otrexup | methotrexate | Antares Pharma, Inc. | INJECTION, SOLUTION | 2013-10-11 | |
| 54436-015 | Otrexup | methotrexate | Antares Pharma, Inc. | INJECTION, SOLUTION | 2013-10-11 | |
| 54436-017 | Otrexup | methotrexate | Antares Pharma, Inc. | INJECTION, SOLUTION | 2013-10-11 | |
| 54436-020 | Otrexup | methotrexate | Antares Pharma, Inc. | INJECTION, SOLUTION | 2013-10-11 | |
| 54436-022 | Otrexup | methotrexate | Antares Pharma, Inc. | INJECTION, SOLUTION | 2013-10-11 | |
| 54436-025 | Otrexup | methotrexate | Antares Pharma, Inc. | INJECTION, SOLUTION | 2013-10-11 | |
| 65219-550 | Pralatrexate | Pralatrexate | Fresenius Kabi USA, LLC | INJECTION | 2022-11-15 | |
| 65219-552 | Pralatrexate | Pralatrexate | Fresenius Kabi USA, LLC | INJECTION | 2022-11-15 | |
| 68382-775 | Methotrexate | Methotrexate | Zydus Pharmaceuticals USA Inc. | TABLET | 2017-02-09 | |
| 70771-1058 | Methotrexate | Methotrexate | Zydus Lifesciences Limited | TABLET | 2017-02-09 | |
| 72893-003 | Folotyn | pralatrexate | Acrotech Biopharma Inc | INJECTION | 2009-09-24 | |
| 72893-005 | Folotyn | pralatrexate | Acrotech Biopharma Inc | INJECTION | 2009-09-24 | |
| 81927-204 | JYLAMVO | Methotrexate | SHORLA ONCOLOGY INC. | SOLUTION | 2023-12-15 | |
| 82497-010 | Otrexup | methotrexate | Otter Pharmaceuticals, LLC | INJECTION, SOLUTION | 2024-09-25 | |
| 82497-012 | Otrexup | methotrexate | Otter Pharmaceuticals, LLC | INJECTION, SOLUTION | 2024-09-25 | |
| 82497-015 | Otrexup | methotrexate | Otter Pharmaceuticals, LLC | INJECTION, SOLUTION | 2024-09-25 | |
| 82497-017 | Otrexup | methotrexate | Otter Pharmaceuticals, LLC | INJECTION, SOLUTION | 2024-09-25 | |
| 82497-020 | Otrexup | methotrexate | Otter Pharmaceuticals, LLC | INJECTION, SOLUTION | 2024-09-25 | |
| 82497-022 | Otrexup | methotrexate | Otter Pharmaceuticals, LLC | INJECTION, SOLUTION | 2024-09-25 | |
| 82497-025 | Otrexup | methotrexate | Otter Pharmaceuticals, LLC | INJECTION, SOLUTION | 2024-09-25 | |
| 83831-111 | PEMETREXED DIPOTASSIUM | pemetrexed dipotassium | Avyxa Pharma, LLC | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2025-01-01 | |
| 83831-112 | PEMETREXED DIPOTASSIUM | pemetrexed dipotassium | Avyxa Pharma, LLC | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2025-01-01 | |
| 83831-131 | AXTLE | pemetrexed | Avyxa Pharma, LLC | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2025-01-01 | |
| 83831-132 | AXTLE | pemetrexed | Avyxa Pharma, LLC | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2025-01-01 |
Loading full table content...